Daniel P. Petro
Hematology Oncology
5115 Centre Avenue, Hillman Cancer Center
Pittsburgh, PA 15232
Pittsburgh, PA 15232
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase Ib study of berzosertib, carboplatin, gemcitabine, and pembrolizumab in patients with squamous nonsmall lung cancer (ETCTN 10313).
Journal: The oncologist
Published: July 09, 2025
Phase I Trial of Cetuximab, Radiotherapy, and Ipilimumab in Locally Advanced Head and Neck Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 02, 2021
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies.
Journal: Cancer chemotherapy and pharmacology
Published: August 18, 2019
SWOG S1400C (NCT02154490)-A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 25, 2019
Initial Results of a Multicenter Phase 2 Trial of Stereotactic Ablative Radiation Therapy for Oligometastatic Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: April 20, 2018
Phase I study of veliparib in combination with gemcitabine.
Journal: Cancer chemotherapy and pharmacology
Published: July 10, 2017
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Journal: Cancer
Published: December 07, 2016
A multicenter phase II study of cetuximab in combination with chest radiotherapy and consolidation chemotherapy in patients with stage III non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 26, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026